NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: Flexi Communications

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Pharmaco Group to Develop New 'know-how' of Medical Products - The enterprise will add to the arsenal new ways of manufacture of medicinal forms, to be exact, will begin working out and introduction of preparations with the prolonged period of validity
Pharmaco Group to Develop New 'know-how' of Medical Products

 

NewswireTODAY - /newswire/ - Bishkek, Kyrgyzstan, Kazakhstan, 2009/05/26 - The enterprise will add to the arsenal new ways of manufacture of medicinal forms, to be exact, will begin working out and introduction of preparations with the prolonged period of validity.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

«The enterprise will add to the arsenal new ways of manufacture of medicinal forms, to be exact, will begin working out and introduction of preparations with the prolonged period of validity», - the head of a pharmaceutical plant Alexander Karpov informed mass-media.

In modern pharmaceutics the theme of creation of the prolonged medicinal forms providing long action of a preparation with simultaneous decrease of its daily dose, gets the increasing urgency. Such medicines with the prolonged action allow not only to increase efficiency of medical therapy in times, considerably having lowered quantity of reception, but also to raise safety of used preparations, to increase their bio-availability.
Alexander Karpov, the general manager of «Pharmaco Group»: «the Idea to let out similar preparations in Kyrgyzstan has come to us in time of visiting the pharmaceutical enterprises in Germany. We have got acquainted with practical techniques of manufacture of medical products, and the received experience has appeared invaluable. In the future we will necessarily apply at plant «Pharmaco Group» new principles of work, the newest representations about functioning of modern systems of the equipment and we will develop, of course, contacts to the largest pharmaceutical producers and suppliers».

The heads of «Pharmaco Group» and technologists of the plant have visited Germany, on 29th international exhibitions and the congress in chemistry, chemical mechanical engineering, protection of environment and biotechnologies - «ACHEMA». Representatives of the Kyrgyz plant have visited leading enterprises of Germany where have reached preliminary arrangements with the largest world manufacturers about raw materials delivery in the Kyrgyz Republic. Also they have familiarized with achievements in the field of the modern technical equipment.
ACHEMA - the biggest international event in the area passes in Germany since 1920. Its organizer is the German society of chemical technical and biotechnology DECHEMA, every three years represents the newest opening and technological decisions at an exhibition and publishes last scientific researches in a congress format. Here the equipment, laboratory and industrial technologies, the literature, safety and control systems etc. are exhibited. In 2009 more than 1200 representatives of the press from every corner of the world covered ACHEMA's work.

«Pharmaco Group» is a pharmaceutical plant located in Bishkek, the Kyrgyz capital. Its annual output equals 500 million pills, 100 million capsules and 12 million vials of antibiotic powders. These medications are used in gastroenterology, dermatology, gynecology, urology, rheumatology, cardiology and pediatrics. In production of «Pharmaco Group» enters medicine brands having own trade descriptions.
«Pharmaco Group» manufacture medicines of different anatomy-therapeutic groups in particular – antibiotics and antibacterial medicines, expectorants, spasmolytics, the remedies improving brain blood circulation, not steroid anti-inflammatory medicines etc.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Flexi Communications

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Pharmaco Group to Develop New 'know-how' of Medical Products

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Elmira Mamytbekova - FlexiCommunications.com 
+996 312 62 25 84 office[.]flexicommunications.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Flexi Communications securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Flexi Communications / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

IQIRVO® Demonstrates Statistically Significant Improvement in ALP Normalization in Patients with PBC in Phase IIIb ELSPIRE Study
Dysport® is the First Botulinum Toxin to Achieve Positive Topline Phase III Results in Both Episodic and Chronic Migraine
STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development
Ipsen to Acquire Memo Therapeutics AG - Adding First-in-class BK Polyomavirus Antibody, Expanding Rare Disease Portfolio
Ipsen to Acquire Kartos Therapeutics, Expanding Hemato-oncology Late-stage Pipeline
Ono Pharma Submits a Supplemental Application in Japan to Expand the Use of VELEXBRU® Tablets for the Treatment of Central Nervous System Involvement
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 in Multiple System Atrophy At the 7th World Parkinson Con
Ipsen Announces Late-breaking Data from First Head-to-head Study Comparing Dysport® and Botox® in Adults with Upper Limb Spasticity
Ipsen Unveils Corabotase, A First-in-class Recombinant Neuroinhibitor, RNI™ At the SCALE Symposium
SCHOTT Pharma Expands Portfolio for Sensitive Biologics with CartriQ® BioPure
Ojemda® Approved in The European Union as the First Targeted Therapy in Relapsed or Refractory Pediatric Low-grade Glioma
Ono Pharma Submits an Application for Approval of Ripretinib (DCC-2618) in Patients with Advanced Gastrointestinal Stromal Tumor in Japan
Locus FS Receives the 2026 North American Precision Fermentation Technology Innovation Leadership Recognition
Ipsen Showcases Transformative Potential of Early Immuno-oncology Pipeline At AACR
Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit BizJobs.com

Visit  JobsWare.com





 
  ©2005-2026 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)